You are here : Home / Quarterly Results / CIPLA LTD

CIPLA Quarterly Results Analysis Q2FY22 [Sep2021]

Q-o-Q REVENUES OPERATING PROFIT PROFIT AFTER TAX EPS Updated : 27-Oct-21 Details👇

CIPLA Quarterly Results

Consolidated Sep2021
Audited
Jun2021
UnAudited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
Audited
Jun2020
UnAudited
Mar2020
Audited
Dec2019
UnAudited
Revenues ₹5,520 Cr ₹5,504 Cr ₹4,606 Cr ₹5,169 Cr ₹5,038 Cr ₹4,346 Cr ₹4,376 Cr ₹4,371 Cr
Expenses ₹4,294 Cr ₹4,158 Cr ₹3,810 Cr ₹3,938 Cr ₹3,862 Cr ₹3,297 Cr ₹3,743 Cr ₹3,613 Cr
Operating Income ₹1,226 Cr ₹1,346 Cr ₹796 Cr ₹1,231 Cr ₹1,177 Cr ₹1,049 Cr ₹634 Cr ₹758 Cr
Other Income ₹61 Cr ₹65 Cr ₹60 Cr ₹87 Cr ₹53 Cr ₹65 Cr ₹93 Cr ₹72 Cr
Interest ₹38 Cr ₹30 Cr ₹27 Cr ₹48 Cr ₹39 Cr ₹46 Cr ₹53 Cr ₹46 Cr
Depreciation ₹253 Cr ₹261 Cr ₹285 Cr ₹248 Cr ₹265 Cr ₹269 Cr ₹346 Cr ₹278 Cr
Profit Before Tax ₹996 Cr ₹996 Cr ₹544 Cr ₹1,021 Cr ₹926 Cr ₹799 Cr ₹328 Cr ₹506 Cr
Profit After Tax ₹712 Cr ₹712 Cr ₹416 Cr ₹753 Cr ₹662 Cr ₹571 Cr ₹242 Cr ₹354 Cr
EPS ₹8.82 ₹8.86 ₹5.13 ₹9.28 ₹8.25 ₹7.17 ₹3.05 ₹4.35

Check out Industry Peers

Peers & Returns1W1M1Y
CIPLA -2.6% -1.7% 17.3%
SUN PHARMACEUTICAL INDUSTRIES -1.1% -5.3% 36.4%
DIVIS LABORATORIES -5.6% -10.5% 28.2%
DR REDDYS LABORATORIES -2.4% -4.1% -6.2%
GLAND PHARMA -3.1% -3.4% 62.5%
PIRAMAL ENTERPRISES 4.5% -4.9% 81.4%
CADILA HEALTHCARE 0.4% -6.6% -0.4%
TORRENT PHARMACEUTICALS 5.5% 8.2% 14.4%
ALKEM LABORATORIES -0.6% -4.2% 22.7%

CIPLA Quarterly Revenues

Revenues
Q-o-Q

0.28 %

Y-o-Y

9.56 %

Quarters Revenues % Change
Sep2021 ₹5,520 Cr
0.28
Jun2021 ₹5,504 Cr
19.49
Mar2021 ₹4,606 Cr
-10.88
Dec2020 ₹5,169 Cr
2.59
Sep2020 ₹5,038 Cr
15.93
Jun2020 ₹4,346 Cr
-0.69
Mar2020 ₹4,376 Cr
0.12
Dec2019 ₹4,371 Cr -

CIPLA Quarterly Operating Profit

Operating Profit
Q-o-Q

-8.89 %

Y-o-Y

4.22 %

Quarters Operating Profit % Change
Sep2021 ₹1,226 Cr
-8.89
Jun2021 ₹1,346 Cr
69.03
Mar2021 ₹796 Cr
-35.31
Dec2020 ₹1,231 Cr
4.62
Sep2020 ₹1,177 Cr
12.19
Jun2020 ₹1,049 Cr
65.54
Mar2020 ₹634 Cr
-16.46
Dec2019 ₹758 Cr -
Operating Margins
Q-o-Q

-9.16 %

Y-o-Y

-4.88 %

Quarters Operating Margin% % Change
Sep2021 22.21%
-9.16
Jun2021 24.45%
41.41
Mar2021 17.29%
-27.38
Dec2020 23.81%
1.97
Sep2020 23.35%
-3.23
Jun2020 24.13%
66.64
Mar2020 14.48%
-16.54
Dec2019 17.35% -

CIPLA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

0.03 %

Y-o-Y

7.58 %

Quarters Profit After Tax % Change
Sep2021 ₹712 Cr
0.03
Jun2021 ₹712 Cr
71.31
Mar2021 ₹416 Cr
-44.78
Dec2020 ₹753 Cr
13.70
Sep2020 ₹662 Cr
15.82
Jun2020 ₹571 Cr
135.83
Mar2020 ₹242 Cr
-31.47
Dec2019 ₹354 Cr -
PAT Margins
Q-o-Q

-0.23 %

Y-o-Y

-1.83 %

Quarters PAT Margin(%) % Change
Sep2021 12.9 %
-0.23
Jun2021 12.93 %
43.35
Mar2021 9.02 %
-38.05
Dec2020 14.56 %
10.81
Sep2020 13.14 %
-0.08
Jun2020 13.15 %
137.36
Mar2020 5.54 %
-31.52
Dec2019 8.09 % -

CIPLA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-0.45 %

Y-o-Y

6.91 %

Quarters EPS % Change
Sep2021 ₹8.82
-0.45
Jun2021 ₹8.86
72.71
Mar2021 ₹5.13
-44.72
Dec2020 ₹9.28
12.48
Sep2020 ₹8.25
15.06
Jun2020 ₹7.17
135.08
Mar2020 ₹3.05
-29.89
Dec2019 ₹4.35 -
STOCK RESEARCH & ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

CIPLA related INDICES

BSE Indices1W1M1Y
S&P BSE GREENEX 0.8% -3.7% 40.1%
S&P BSE ALLCAP 0.7% -2.8% 38.3%
S&P BSE 500 0.6% -3% 37.1%
S&P BSE LARGE MIDCAP 0.6% -3.1% 34.2%
S&P BSE 200 0.6% -3.1% 34.8%
S&P BSE 250 LARGEMIDCAP 0.5% -3.1% 35.5%
S&P BSE CARBONEX 0.5% -3.1% 32.2%
S&P BSE 100 0.5% -3.1% 32.6%
S&P BSE 100 ESG INDEX 0.4% -3.3% 33.5%
S&P BSE LARGECAP 0.4% -3.1% 32.1%
S&P BSE 100 LARGECAP TMC 0.4% -3.1% 32.5%
MFG 0.4% -4.4% 30.8%
S&P BSE SENSEX50 0.4% -3.3% 31.3%
S&P BSE DIVIDEND STABILITY -0.2% -7.3% 32.6%
S&P BSE HEALTHCARE -1.2% -0.5% 20.1%
NSE Indices1W1M1Y
NIFTY500 MULTICAP 50:25:25 1% -2.4% NA
NIFTY LARGE MIDCAP 250 0.8% -2.8% 41.7%
NIFTY 100 EQUAL WEIGHT 0.8% -3.7% 39.2%
NIFTY 500 0.7% -2.9% 36.9%
NIFTY 100 ALPHA 30 0.6% 0.7% NA
NIFTY 200 0.6% -3.1% 34.4%
NIFTY 100 0.4% -3.1% 32.1%
NIFTY 50 0.4% -3.3% 31%
NIFTY50 EQUAL WEIGHT 0.4% -4.3% 39.4%
NIFTY ALPHA LOW-VOLATILTY 30 0.1% -2.6% 30.9%
NIFTY100 LOW VOLATILITY 30 -0.7% -4% 25.9%
NIFTY PHARMA -0.9% -3% 9.9%
NIFTY HEALTHCARE -1.4% -0.6% NA

You may also like the below Video Courses

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Share Price & Financials of PIRAMAL ENTERPRISES LTD | BOM: 500302 | NSE: PEL
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of ALKEM LABORATORIES LTD | BOM: 539523 | NSE: ALKEM
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Share Price & Financials of LAURUS LABS LTD | BOM: 540222 | NSE: LAURUSLABS
Share Price & Financials of IPCA LABORATORIES LTD | BOM: 524494 | NSE: IPCALAB

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z